NEW 4th Generation PRRS Vaccine

MJ Biologics, Inc. is a research company located in Mankato, Minnesota and is dedicated to the research and development of animal health products including autogenous MJPRRS® vaccine for PRRS control. Our commitment has now yielded a 4th Generation MJPRRS Vaccine to be used as a tool to help producers minimize production losses and survive PRRSV challenges during this difficult economic environment.

*Based on a recent study, PRRS costs the U.S. pork industry $664 million each year in production losses and nearly another $478 million in veterinary, biosecurity and other outbreak related costs. That's a total of more than $1.14 billion per year, or over $3.1 million per day.

In The News

» Phibro Animal Health Corporation Announces Entry into Collaboration Agreement, License Agreement and Intellectual Property Acquisition Agreement

» Retrospective Analysis by Novel Methodology of PRRSv Field Strains in an Area-Regional Control and Elimination Project

» The use of MJPRRS Vaccine as a tool for managing and stabilizing PRRS infections in sow and pig populations

» MJPRRS technology is one of the tools used in farms in West Michigan Control Project, to help successfully control PRRS.
Dr. Tim Loula consulting veterinarian

» NEW Scientific Nursery Pig Control Study was presented at the June, 2012 IPVS Meeting in Korea by Vietnam Government Scientists

» Control Study in Nursery Pigs Presented at the 2012 AASV Meeting

» 2011 American Association of Swine Veterinarians Presentation

» 2010 American Association of Swine Veterinarians Presentation

» Feedstuffs Magazine Article - Priming PRRS vaccine may offer viral control (July 27, 2011)

» Heterologous Pregnant Gilt Challenge Study with Statistically Significant Results Presented by Darwin Reicks, DVM at the Leman Swine Conference, St. Paul, Minnesota

» The Farmer Magazine - Vaccine May Help Eradicate PRRS

» Mankato Free Press Article - Mankato Company Develops Hog Vaccine

» MVP Laboratories partners with MJ Biologics to combat PRRSV
  • Current generation of autogenous killed MJPRRS vaccine is a tool for PRRS stabilization and control in PRRS positive herds and is not designed for use as a stand alone vaccine in a PRRS naive herd.
  • MJPRRS vaccine is an autogenous vaccine exclusively produced, distributed, and sold by MVP Laboratories Inc. in Omaha Nebraska. MVP autogenous vaccines are produced in MVP's USDA licensed facilities and are only available through veterinarians.
  • MJPRRS autogenous vaccine requires authorization for use by the attending veterinarian.
*Holtkamp, Derald J.; Kliebenstein, James B.; Zimmerman, Jeffrey J.; Neumann, Eric; Rotto, Hans; Yoder, Tiffany; Wang, Chong; Yeske, Paul; Mowrer, Christine; and Haley, Charles (2012) "Economic Analysis of PRRS Virus Elimination from a Herd," Animal Industry Report: AS 658, ASL R2678.
Available at: